How certain receptors in blood vessels affect insulin resistance in muscles due to a high-fat diet
Endothelial mineralocorticoid receptors in diet-induced skeletal muscle insulin resistance
This study is looking at how eating a lot of fatty and sugary foods can make it harder for your muscles to respond to insulin, which is important for managing blood sugar, and it focuses on how certain receptors in blood vessel cells play a role in this process.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10991332 on NIH RePORTER |
What this research studies
This research investigates how a diet high in fat and sugars can lead to insulin resistance in skeletal muscles by activating specific receptors in blood vessel cells. It focuses on the role of endothelial mineralocorticoid receptors (MRs) and their impact on lipid metabolism and insulin signaling. By examining the relationship between these receptors and muscle lipid accumulation, the study aims to uncover mechanisms that contribute to metabolic disorders. The research utilizes advanced techniques to analyze cellular interactions and the effects of dietary components on muscle function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are experiencing insulin resistance or have a high-fat diet.
Not a fit: Patients who do not have insulin resistance or are not consuming a high-fat diet may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating insulin resistance and related metabolic disorders in patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of endothelial receptors in metabolic disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Jia, Guanghong — University of Missouri-Columbia
- Study coordinator: Jia, Guanghong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.